000560 (1998) |
Korczyn [Israël] ; David J. Brooks [Royaume-Uni] ; Ehrout R. Brunt [Pays-Bas] ; Warner H. Poewe [Autriche] ; Olivier Rascol [France] ; Fabrizzio Stocchi [Italie] | Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6‐month interim report of a 3‐year study |
000574 (1998) |
A. D. Korczyn [Israël] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; F. Stocchi [Italie] | Ropinirole versus bromocriptine in the treatment of early Parkinson's disease : A 6-month interim report of a 3-year study |
000561 (1998) |
Rascol [France] ; David J. Brooks [Royaume-Uni] ; Ehrout R. Brunt [Pays-Bas] ; Amos D. Korczyn [Israël] ; Warner H. Poewe [Autriche] ; Fabrizzio Stocchi [Italie] | Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study |
000575 (1998) |
Olivier Rascol [France] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; A. D. Korczyn [Israël] ; Werner Poewe [Autriche] ; F. Stocchi [Italie] | Ropinirole in the treatment of early Parkinson's disease : A 6-month interim report of a 5-year levodopa-controlled study |
000353 (2006) |
Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France] | The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease |
000384 (2006) |
Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France] | The parkinson-control study : A 1-year randomized, double- blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in parkinson's disease |
000369 (2006) |
Olivier Rascol [France] ; Bruno Dubois [France] ; Alexandre Castro Caldas [Portugal] ; Stephen Senn [Royaume-Uni] ; Susanna Del Signore [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study |
000371 (2006) |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
000314 (2007) |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa |
000322 (2007) |
Robert A. Hauser [États-Unis] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Victor L. Konyago [États-Unis] | Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease |
000455 (2003) |
Marc Ziegler ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France] | Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6‐month, randomized, placebo‐controlled study |
000024 (2015) |
Raphael Carapito [France] ; Nicodème Paul ; Meiggie Untrau ; Marion Le Gentil ; Louise Ott ; Ghada Alsaleh ; Pierre Jochem ; Mirjana Radosavljevic ; Cédric Le Caignec ; Albert David ; Philippe Damier ; Bertrand Isidor ; Seiamak Bahram | A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia. |
000046 (2014) |
Kathy Dujardin [France] ; Carole Langlois ; Lucie Plomhause ; Anne-Sophie Carette ; Marie Delliaux ; Alain Duhamel ; Luc Defebvre [France] | Apathy in untreated early-stage Parkinson disease: relationship with other non-motor symptoms. |
000083 (2013) |
Claude Vital [France] ; Anne Vital | Are substantia nigra neurons subject to mitochondrial dysfunction in early life more able to adapt? |
000107 (2012) |
Suhan Senova [France] ; Bechir Jarraya [France] ; Hiro Iwamuro [France] ; Naoki Tani [France] ; Naoufel Ouerchefani [France] ; Helene Lepetit [France] ; Jean-Marc Gurruchaga [France] ; Pierre Brugieres [France] ; Emmanuelle Apartis [France] ; Thomas De Broucker [France] ; Stephane Palfi [France] | Unilateral Thalamic Stimulation Safely Improved Fragile X-Associated Tremor Ataxia: A Case Report |
000116 (2012) |
Christina Meyer [Allemagne] ; Bernhard Landwehrmeyer [Allemagne] ; Carsten Schwenke [Allemagne] ; Adam Doble [France] ; Michael Orth [Allemagne] ; Albert C. Ludolph [Allemagne] | Rate of Change in Early Huntington's Disease: a Clinicometric Analysis |
000132 (2012) |
Fanny Mochel [France] ; Tra-My N'Guyen [France] ; Dinesh Deelchand [États-Unis] ; Daisy Rinaldi [France] ; Romain Valabregue [France] ; Claire Wary [France] ; Pierre G. Carlier [France] ; Alexandra Durr [France] ; Pierre-Gilles Henry [États-Unis] | Abnormal Response to Cortical Activation in Early Stages of Huntington Disease |
000151 (2011) |
Julia Grossac [France] ; Stéphanie Ruiz [France] ; Emmanuelle Bondon-Guitton [France] ; Franck-Emmanuel Roux [France] ; Olivier Fourcade [France] ; Jean-Louis Montastruc [France] ; Thomas Geeraerts [France] | Severe intracranial bleeding related to vitamin K Antagonist‐Ropinirole interaction |
000157 (2011) |
Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas] | Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials |
000176 (2011) |
Andreas Kupsch [Allemagne] ; Michele Tagliati [États-Unis] ; Marie Vidailhet [France] ; Tipu Aziz [Royaume-Uni] ; Paul Krack [France] ; Elena Moro [Canada] ; Joachim K. Krauss [Allemagne] | Early postoperative management of DBS in dystonia: Programming, response to stimulation, adverse events, medication changes, evaluations, and troubleshooting |
000190 (2010) |
Carlo Colosimo [Italie] ; Pablo Martínez-Martín [Espagne] ; Giovanni Fabbrini [Italie] ; Robert A. Hauser [États-Unis] ; Marcelo Merello [Argentine] ; Janis Miyasaki [Canada] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis] | Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations |
000200 (2010) |
Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche] | Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease |
000217 (2010) |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
000219 (2010) |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas] | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
000238 (2009) |
André R. Troiano [France] ; Paulo C. Trevisol-Bittencourt [Brésil] | Re: Chorea‐acanthocytosis: Report of two Brazilian cases |
000250 (2009) |
Nathalie Chastan [France] ; Jacques Weber [France] | Infraclinical postural instability in early‐stage Parkinson's disease? |
000289 (2008) |
Guilherme G. Riccioppo Rodrigues ; Ruth H. Walker [États-Unis] ; Alexis Brice [France] ; Cécile Cazeneuve [France] ; Odile Russaouen [France] ; Helio A. G. Teive [Brésil] ; Renato Puppi Munhoz [Brésil] ; Nilson Becker [Brésil] ; Salmo Raskin [Brésil] ; Lineu Cesar Werneck [Brésil] ; Wilson Marques Junior ; Vitor Tumas | Huntington's disease‐like 2 in Brazil—Report of 4 patients |
000291 (2008) |
Christoph Globas [Allemagne] ; Sophie Tezenas Du Montcel [France] ; Laslo Baliko [Hongrie] ; Syliva Boesch [Autriche] ; Chantal Depondt [Belgique] ; Stefano Didonato [Italie] ; Alexandra Durr [France] ; Alessandro Filla [Italie] ; Thomas Klockgether [Allemagne] ; Caterina Mariotti [Italie] ; Bela Melegh [Hongrie] ; Maryla Rakowicz [Pologne] ; Pascale Ribai [France] ; Rafal Rola [Pologne] ; Tanja Schmitz-Hubsch [Allemagne] ; Sandra Szymanski [Allemagne] ; Dagmar Timmann [Allemagne] ; Bart P. Van De Warrenburg [Pays-Bas] ; Peter Bauer [Allemagne] ; Ludger Schols [Allemagne] | Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6 |
000292 (2008) |
Mathieu Anheim [France] ; Laurent Vercueil [France] ; Valerie Fraix [France] ; Stéphan Chabardès [France] ; Eric Seigneuret [France] ; Paul Krack [France] ; Alim-Louis Benabid [France] ; Marie Vidailhet [France] ; Pierre Pollak [France] | Early stimulation of DYT1 primary generalized dystonia prevents from its secondary irreversible complications |
000293 (2008) |
Agnès Annic [France] ; David Devos [France] ; Alain Destée [France] ; Luc Defebvre [France] ; Arnaud Lacour [France] ; Jean-François Hurtevent [France] ; Tanya Stojkovic [France] | Early dopasensitive Parkinsonism related to myotonic dystrophy type 2 |
000295 (2008) |
Nathalie Chastan [France] ; Bertrand Debono [France] ; David Maltête [France] ; Jacques Weber [France] | Discordance between measured postural instability and absence of clinical symptoms in Parkinson's disease patients in the early stages of the disease |
000309 (2008) |
Guilherme G. Riccioppo Rodrigues [Brésil] ; Ruth H. Walker [États-Unis] ; Alexis Brice [France] ; Cécile Cazeneuve [France] ; Odile Russaouen [France] ; Helio A. G. Teive [Brésil] ; Renato Puppi Munhoz [Brésil] ; Nilson Becker [Brésil] ; Salmo Raskin [Brésil] ; Lineu Cesar Wemeck [Brésil] ; Wilson Marques Junior [Brésil] ; Vitor Tumas [Brésil] | Huntington's Disease-Like 2 in Brazil-Report of 4 Patients |
000317 (2007) |
Christopher G. Goetz [États-Unis] ; Philippe Damier [France] ; Christine Hicking [Allemagne] ; Eugene Laska [États-Unis] ; Thomas Müller [Allemagne] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Hermann Russ [Allemagne] | Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double‐blind placebo‐controlled trial |
000320 (2007) |
Pierre Krystkowiak [France] ; Sophie Tezenas Du Montcel [France] ; Laurent Vercueil [France] ; Jean-Luc Houeto [France] ; Christelle Lagrange [France] ; Philippe Cornu [France] ; Serge Blond [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Marie Vidailhet [France] | Reliability of the Burke‐Fahn‐Marsden scale in a multicenter trial for dystonia |
000357 (2006) |
Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lled [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne] | Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study |
000431 (2004) |
Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Carl Counsell [Portugal] ; Nir Giladi [Israël] ; Robert G. Holloway [États-Unis] ; Charity G. Moore [États-Unis] ; Gregor K. Wenning [Autriche] ; Melvin D. Yahr [États-Unis] ; Lisa Seidl [États-Unis] | Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease |
000444 (2003) |
Jan Herzog [Allemagne] ; Jens Volkmann [Allemagne] ; Paul Krack [Allemagne, France] ; Florian Kopper [Allemagne] ; Monika Pötter [Allemagne] ; Delia Lorenz [Allemagne] ; Meike Steinbach [Allemagne] ; Stefan Klebe [Allemagne] ; Wolfgang Hamel [Allemagne] ; Bettina Schrader [Allemagne] ; Dieter Weinert [Allemagne] ; Dieter Müller [Allemagne] ; Hubertus M. Mehdorn [Allemagne] ; Günther Deuschl [Allemagne] | Two‐year follow‐up of subthalamic deep brain stimulation in Parkinson's disease |
000450 (2003) |
Michael P. Hill [Royaume-Uni] ; Erwan Bezard [France] ; Steven G. Mcguire [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Ann Michel [Belgique] ; Renee Grimée [Belgique] ; Henrik Klitgaard [Belgique] | Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L‐dopa and ropinirole in the MPTP‐lesioned marmoset |
000472 (2002) |
Stéphanie Thobois [France] ; Pierric Giraud [France] ; Pierre Debat [France] ; Michel Gouttard [France] ; Anne Maurizi [France] ; Armand Perret-Liaudet [France] ; Nicolas Kopp [France] ; Emmanuel Broussolle [France] | Orofacial dyskinesias in a patient with primary biliary cirrhosis: A clinicopathological case report and review |
000473 (2002) |
Pierre Bertholon [France] ; Philippe Convers [France] ; Jean Christophe Antoine [France] ; Régis Mayaud [France] ; Jean Michel Prades [France] ; Daniel Michel [France] ; Christian Martin [France] | Objective tinnitus associated with essential laryngeal myoclonus: Report of two cases |
000479 (2002) |
Marie-Paule Muriel [France] ; Gaël Orieux [France] ; Etienne C. Hirsch [France] | Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats |
000490 (2002) |
Sandhiran Patchay [France, Royaume-Uni] ; Yves Gahéry [France] ; Georges Serratrice [France] | Early postural adjustments associated with gait initiation and age‐related walking difficulties |
000508 (2001) |
Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France] | Long‐term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease |
000514 (2001) |
Pierre-François Pradat [France] ; Corinne Dupel-Pottier [France] ; Lucette Lacomblez [France] ; François Salachas [France] ; Vincent Meininger [France] ; Lucette Lacomblez [France] ; Laurent Spelle [France] ; Isabelle Bonnaud [France] ; Marie Joao Ribeiro [France] ; Philippe Remy [France] ; Yves Samson [France] | Case report of pallido‐pyramidal disease with supplementary motor area involvement |
000529 (2000) |
G. Demarquay [France] ; A. Setiey [France] ; Y. Morel [France] ; C. Trepo [France] ; G. Chazot [France] ; E. Broussolle [France] | Clinical report of three patients with hereditary hemochromatosis and movement disorders |
000619 (1995) |
Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France] | A “combined” levodopa test as a useful method for evaluating the efficacy of dopamine agonists: Application to pergolide and bromocriptine |
000625 (1995) |
A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France] | A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine |
000669 (1989) |
M. H. Marion [France] ; R. F. Gledhill [Afrique du Sud] ; Thompson [Royaume-Uni] | Spasms of amputation stumps: A report of 2 cases |